A closer look at the validation pathway

Why validation moves in stages

Researchers cannot answer every question in one experiment. NanoFlash therefore plans to begin with cells and human retinal organoids before moving to retinal explants and, later, rodent models.

Each step narrows uncertainty before the research moves towards a more complete biological system.

Three planned environments

1. In vitro: cells and human retinal organoids.
2. Ex vivo: retinal explants.
3. In vivo: later studies in rodent models.

These are research stages, not confirmed clinical outcomes. The process is intended to examine targeting, response and safety questions carefully.